These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 31803127)

  • 1. Quantifying the Metabolic Signature of Multiple Sclerosis by
    Swanberg KM; Landheer K; Pitt D; Juchem C
    Front Neurol; 2019; 10():1173. PubMed ID: 31803127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo proton magnetic resonance spectroscopy of human spinal mass lesions.
    Kim YG; Choi GH; Kim DH; Kim YD; Kang YK; Kim JK
    J Spinal Disord Tech; 2004 Oct; 17(5):405-11. PubMed ID: 15385881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in multiple sclerosis.
    Sajja BR; Wolinsky JS; Narayana PA
    Neuroimaging Clin N Am; 2009 Feb; 19(1):45-58. PubMed ID: 19064199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3D proton MR spectroscopy of the gray and white brain matter. A study of 15 volunteers].
    Tyurina AN; Fadeeva LM; Kornienko VN; Zakharova NE; Batalov AI; Mertsalova MP; Rodionov PV; Pogosbekyan EL; Pronin IN
    Zh Vopr Neirokhir Im N N Burdenko; 2018; 82(6):23-29. PubMed ID: 30721214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H magnetic resonance spectroscopy in multiple sclerosis and related disorders.
    Rovira A; Alonso J
    Neuroimaging Clin N Am; 2013 Aug; 23(3):459-74. PubMed ID: 23928200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and applications of in vivo clinical magnetic resonance spectroscopy.
    Cox IJ
    Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel.
    Heo H; Kim S; Lee HH; Cho HR; Xu WJ; Lee SH; Park CK; Park S; Choi SH; Kim H
    PLoS One; 2016; 11(1):e0147794. PubMed ID: 26820720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Errors in
    Gasparovic C; Chen H; Mullins PG
    NMR Biomed; 2018 Jun; 31(6):e3914. PubMed ID: 29727496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
    Vafaeyan H; Ebrahimzadeh SA; Rahimian N; Alavijeh SK; Madadi A; Faeghi F; Harirchian MH; Rad HS
    Australas Phys Eng Sci Med; 2015 Dec; 38(4):611-8. PubMed ID: 26526449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis in magnetic resonance spectroscopy: from metabolic profiling to in vivo biomarkers.
    Serkova NJ; Brown MS
    Bioanalysis; 2012 Feb; 4(3):321-41. PubMed ID: 22303835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the optimal schedule for multiparametric MRS? A magnetic resonance fingerprinting perspective.
    Kulpanovich A; Tal A
    NMR Biomed; 2021 May; 34(5):e4196. PubMed ID: 31814197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel (1)H-MRS at 1.5 T.
    Chernov MF; Muragaki Y; Maruyama T; Ono Y; Usukura M; Yoshida S; Nakamura R; Iseki H; Kubo O; Hori T; Takakura K
    Neuroradiology; 2009 Mar; 51(3):137-43. PubMed ID: 18949472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study.
    Sarchielli P; Presciutti O; Tarducci R; Gobbi G; Alberti A; Pelliccioli GP; Orlacchio A; Gallai V
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):204-12. PubMed ID: 9489531
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Bhogal AA; Schür RR; Houtepen LC; van de Bank B; Boer VO; Marsman A; Barker PB; Scheenen TWJ; Wijnen JP; Vinkers CH; Klomp DWJ
    NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28915314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.
    Orije J; Kara F; Guglielmetti C; Praet J; Van der Linden A; Ponsaerts P; Verhoye M
    Neuroimage; 2015 Jul; 114():128-35. PubMed ID: 25871629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra- and inter-site reproducibility of human brain single-voxel proton MRS at 3 T.
    Graf C; MacMillan EL; Fu E; Harris T; Traboulsee A; Vavasour IM; MacKay AL; Mädler B; Li DKB; Laule C
    NMR Biomed; 2019 Jun; 32(6):e4083. PubMed ID: 30889311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical guide to in vivo proton magnetic resonance spectroscopy at high magnetic fields.
    Xin L; Tkáč I
    Anal Biochem; 2017 Jul; 529():30-39. PubMed ID: 27773654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of
    Parto Dezfouli MA; Parto Dezfouli M; Ahmadian A; Frangi AF; Esmaeili Rad M; Saligheh Rad H
    NMR Biomed; 2017 Feb; 30(2):. PubMed ID: 28052436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the metabolic alterations in a depressive-like rat model of chronic forced swim stress: An in vivo proton magnetic resonance spectroscopy study at 7T.
    Yoo CH; Lim SI; Song KH; Woo DC; Choe BY
    Neurochem Int; 2018 Jun; 116():22-29. PubMed ID: 29530754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy.
    van Walderveen MA; Barkhof F; Pouwels PJ; van Schijndel RA; Polman CH; Castelijns JA
    Ann Neurol; 1999 Jul; 46(1):79-87. PubMed ID: 10401783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.